163 related articles for article (PubMed ID: 2113031)
41. Direct protective effect of NAD(P)H:quinone reductase against menadione-induced chemiluminescence of postmitochondrial fractions of mouse liver.
Prochaska HJ; Talalay P; Sies H
J Biol Chem; 1987 Feb; 262(5):1931-4. PubMed ID: 2434474
[TBL] [Abstract][Full Text] [Related]
42. Dicoumarol-sensitive glucuronidation of benzo(a)pyrene metabolites in rat liver microsomes.
Segura-Aguilar JE; Barreiro V; Lind C
Arch Biochem Biophys; 1986 Nov; 251(1):266-75. PubMed ID: 2431654
[TBL] [Abstract][Full Text] [Related]
43. Mitochondrial NADH-quinone oxidoreductase of the outer membrane is responsible for paraquat cytotoxicity in rat livers.
Shimada H; Hirai K; Simamura E; Pan J
Arch Biochem Biophys; 1998 Mar; 351(1):75-81. PubMed ID: 9500851
[TBL] [Abstract][Full Text] [Related]
44. Metabolism of diaziquone by NAD(P)H:(quinone acceptor) oxidoreductase (DT-diaphorase): role in diaziquone-induced DNA damage and cytotoxicity in human colon carcinoma cells.
Siegel D; Gibson NW; Preusch PC; Ross D
Cancer Res; 1990 Nov; 50(22):7293-300. PubMed ID: 2121335
[TBL] [Abstract][Full Text] [Related]
45. Influence of DT diaphorase on quinone-mediated genotoxicity in human and fish cell lines.
Hasspieler BM; Haffner GD; Adeli K
Mutat Res; 1996 May; 360(1):43-9. PubMed ID: 8657209
[TBL] [Abstract][Full Text] [Related]
46. Substituted vitamin K epoxide analogues. New competitive inhibitors and substrates of vitamin K1 epoxide reductase.
Ryall RP; Nandi DL; Silverman RB
J Med Chem; 1990 Jun; 33(6):1790-7. PubMed ID: 2342073
[TBL] [Abstract][Full Text] [Related]
47. Cephalosporin-induced alteration in hepatic glutathione redox state. A potential mechanism for inhibition of hepatic reduction of vitamin K1,2,3-epoxide in the rat.
Mitchell MC; Mallat A; Lipsky JJ
J Clin Invest; 1990 Nov; 86(5):1589-94. PubMed ID: 1978724
[TBL] [Abstract][Full Text] [Related]
48. Purification of a vitamin K epoxide reductase that catalyzes conversion of vitamin K 2,3-epoxide to 3-hydroxy-2-methyl-3-phytyl-2,3-dihydronaphthoquinone.
Mukharji I; Silverman RB
Proc Natl Acad Sci U S A; 1985 May; 82(9):2713-7. PubMed ID: 3857611
[TBL] [Abstract][Full Text] [Related]
49. Activation and deactivation of quinones catalyzed by DT-diaphorase. Evidence for bioreductive activation of diaziquone (AZQ) in human tumor cells and detoxification of benzene metabolites in bone marrow stroma.
Ross D; Siegel D; Gibson NW; Pacheco D; Thomas DJ; Reasor M; Wierda D
Free Radic Res Commun; 1990; 8(4-6):373-81. PubMed ID: 2113030
[TBL] [Abstract][Full Text] [Related]
50. Tris(3-hydroxypropyl)phosphine is superior to dithiothreitol for in vitro assessment of vitamin K 2,3-epoxide reductase activity.
Krettler C; Bevans CG; Reinhart C; Watzka M; Oldenburg J
Anal Biochem; 2015 Apr; 474():89-94. PubMed ID: 25524619
[TBL] [Abstract][Full Text] [Related]
51. NAD(P)H:quinone oxidoreductase 1 reduces the mutagenicity of DNA caused by NADPH:P450 reductase-activated metabolites of benzo(a)pyrene quinones.
Joseph P; Jaiswal AK
Br J Cancer; 1998 Mar; 77(5):709-19. PubMed ID: 9514048
[TBL] [Abstract][Full Text] [Related]
52. One- and two-electron reduction of quinones by rat liver subcellular fractions.
Nakamura M; Hayashi T
J Biochem; 1994 Jun; 115(6):1141-7. PubMed ID: 7982895
[TBL] [Abstract][Full Text] [Related]
53. Vitamin K epoxide reductase activity in the metabolism of epoxides.
Liptay-Reuter I; Dose K; Guenthner T; Wörner W; Oesch F
Biochem Pharmacol; 1985 Aug; 34(15):2617-20. PubMed ID: 4015704
[TBL] [Abstract][Full Text] [Related]
54. The effects of salicylate on enzymes of vitamin K metabolism.
Hildebrandt EF; Suttie JW
J Pharm Pharmacol; 1983 Jul; 35(7):421-6. PubMed ID: 6136582
[TBL] [Abstract][Full Text] [Related]
55. Antioxidant and prooxidant functions of DT-diaphorase in quinone metabolism.
Cadenas E
Biochem Pharmacol; 1995 Jan; 49(2):127-40. PubMed ID: 7530954
[No Abstract] [Full Text] [Related]
56. Carbonyl reductase provides the enzymatic basis of quinone detoxication in man.
Wermuth B; Platts KL; Seidel A; Oesch F
Biochem Pharmacol; 1986 Apr; 35(8):1277-82. PubMed ID: 3083821
[TBL] [Abstract][Full Text] [Related]
57. Assessment of the contribution of NAD(P)H-dependent quinone oxidoreductase 1 (NQO1) to the reduction of vitamin K in wild-type and NQO1-deficient mice.
Ingram BO; Turbyfill JL; Bledsoe PJ; Jaiswal AK; Stafford DW
Biochem J; 2013 Nov; 456(1):47-54. PubMed ID: 24015818
[TBL] [Abstract][Full Text] [Related]
58. Caffeine, aminoimidazolecarboxamide and dicoumarol, inhibitors of NAD(P)H dehydrogenase (quinone) (DT diaphorase), prevent both the cytotoxicity and DNA interstrand crosslinking produced by 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) in Walker cells.
Roberts JJ; Marchbank T; Kotsaki-Kovatsi VP; Boland MP; Friedlos F; Knox RJ
Biochem Pharmacol; 1989 Nov; 38(22):4137-43. PubMed ID: 2480794
[TBL] [Abstract][Full Text] [Related]
59. Characterization of FMN-dependent NADH-quinone reductase induced by menadione in Escherichia coli.
Hayashi M; Hasegawa K; Oguni Y; Unemoto T
Biochim Biophys Acta; 1990 Aug; 1035(2):230-6. PubMed ID: 2118386
[TBL] [Abstract][Full Text] [Related]
60. R- and S-Warfarin inhibition of vitamin K and vitamin K 2,3-epoxide reductase activities in the rat.
Fasco MJ; Principe LM
J Biol Chem; 1982 May; 257(9):4894-901. PubMed ID: 7068669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
